Cargando…

The association of cardiac troponin and cardiovascular events in patients with concomitant heart failure preserved ejection fraction and atrial fibrillation

BACKGROUND: Limited data are available for risk stratification in patients with atrial fibrillation (AF) and combined heart failure with preserved ejection fraction (HFpEF). We aimed to explore the prognostic utility of high-sensitivity cardiac troponin I (hs-cTnI) in patients with newly detected AF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Bum Sung, Kwon, Chang Hee, Chang, Haseong, Choi, Ji-Hoon, Kim, Hyun-Joong, Kim, Sung Hea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207698/ https://www.ncbi.nlm.nih.gov/pubmed/37226163 http://dx.doi.org/10.1186/s12872-023-03302-y

Ejemplares similares

Predictors and prognostic impact of post-operative atrial fibrillation in patients with hip fracture surgery
por: Bae, Seong Jun, et al.
Publicado: (2022)

Association between preoperative high sensitive troponin I levels and cardiovascular events after hip fracture surgery in the elderly
por: Kim, Bum Sung, et al.
Publicado: (2018)

Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
por: Kuo, Jen-Yuan, et al.
Publicado: (2022)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
por: Ţica, Otilia, et al.
Publicado: (2022)

Long‐term events following catheter‐ablation for atrial fibrillation in heart failure with preserved ejection fraction
por: Ishiguchi, Hironori, et al.
Publicado: (2022)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction
por: McManus, David D., et al.
Publicado: (2013)

The Impact of Metabolic Syndrome on the Incidence of Atrial Fibrillation: A Nationwide Longitudinal Cohort Study in South Korea
por: Kwon, Chang Hee, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation
por: Krishnamurthy, Amrita, et al.
Publicado: (2022)

The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction
por: Weerts, Jerremy, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention
por: Chang, Haseong, et al.
Publicado: (2021)

Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post‐hoc analysis of the ATHENA trial
por: Vaduganathan, Muthiah, et al.
Publicado: (2022)

Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction
por: Liu, Xiao, et al.
Publicado: (2022)

Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction
por: Al-Sadawi, Mohammed, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
por: Fauchier, Laurent, et al.
Publicado: (2023)

Preprocedural Troponin T Levels Predict the Improvement in the Left Ventricular Ejection Fraction After Catheter Ablation of Atrial Fibrillation/Flutter
por: Aoyama, Daisetsu, et al.
Publicado: (2020)

Effects of rhythm control on left atrial structure remodeling in atrial fibrillation and heart failure with preserved ejection fraction
por: Bai, Lin, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
por: Gierula, John, et al.
Publicado: (2022)

Atrial fibrillation ablation in patients with heart failure with preserved ejection fraction: Complexities in diagnosis and treatment
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2022)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction
por: Chen, Chaofeng, et al.
Publicado: (2022)

High‐Sensitivity Cardiac Troponin: From Patient Phenotypes to Clinical Events in Patients With Heart Failure With Preserved Ejection Fraction
por: Bozkurt, Biykem
Publicado: (2018)

E/e’ Ratio Predicts the Atrial Pacing-Induced Left Atrial Pressure Response in Patients with Preserved Ejection Fraction
por: Roh, Seung-Young, et al.
Publicado: (2023)

Loss of myeloid differentiation protein 1 promotes atrial fibrillation in heart failure with preserved ejection fraction
por: Shuai, Wei, et al.
Publicado: (2020)

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta‐analysis
por: Gu, Gaoyang, et al.
Publicado: (2022)

Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
por: Yang, Eunice, et al.
Publicado: (2022)

Impact of catheter ablation for persistent atrial fibrillation with heart failure, compared to preserved and reduced ejection fraction
por: Inamura, Y, et al.
Publicado: (2023)

Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction
por: Nakatani, Daisaku, et al.
Publicado: (2022)

Long-Term Outcomes of Real-World Korean Patients with Atrial-Fibrillation-Related Stroke and Severely Decreased Ejection Fraction
por: Jung, Jin-Man, et al.
Publicado: (2019)

Prognostic significance of high-sensitivity cardiac troponin in patients with heart failure with preserved ejection fraction
por: Suzuki, Sho, et al.
Publicado: (2019)

Personalized Management for Heart Failure with Preserved Ejection Fraction
por: Lin, Chang-Yi, et al.
Publicado: (2023)

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
por: Abdul-Rahim, Azmil H., et al.
Publicado: (2017)

Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation
por: Schönbauer, Robert, et al.
Publicado: (2021)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
por: Lin, Yu‐Sheng, et al.
Publicado: (2022)

Epicardial Adipose Tissue and Development of Atrial Fibrillation (AFIB) and Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Zain, Sarmad, et al.
Publicado: (2023)

Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction
por: Shin, Sung‐Hee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5vd095h3p9j7mtfpaap991imf0